乳腺癌随访中MRI应用的指南与推荐:综述
本文按PRISMA对2006至2016年MedBase、PubMed和Embase文献进行检索,分析10篇文献和8部指南关于乳腺癌治疗后常规随访中MRI应用的建议。仅1篇文献认为MRI可影响后续策略,其余未发现MRI优于乳腺X线摄影或结论不确定;关于有乳腺癌个人史且无其他危险因素患者,1部指南推荐每年MRI,1部指南不提供MRI,其余指南结论不确定。结论认为证据不足,MRI不应提供给无复发风险增加的患者。
要点
- 有乳腺癌个人史且无其他危险因素者,各指南对常规随访是否每年MRI意见不一致。
- 多数文献未发现MRI在常规随访中优于乳腺X线摄影,或结论不确定。
- 作者结论认为MRI不改善所有患者生存,不应提供给无复发风险增加者。
核心结论
- 关于有乳腺癌个人史患者常规随访中MRI是否优于乳腺X线摄影,证据不足。
- MRI不改善所有患者生存,因此不应提供给无复发风险增加的患者。
研究设计与样本
- 综述,按PRISMA进行文献检索,检索词为Magnetic Resonance Imaging、breast neoplasm、post-operative period和follow-up。
- 检索2006年至2016年MedBase、PubMed和Embase发表的文献,最终分析10篇文献和8部指南。
诊断标准与关键数值
- 1篇文献结论认为MRI可影响后续策略,其余文献未发现MRI优于乳腺X线摄影或结论不确定。
- 1部指南推荐对有乳腺癌个人史且无其他危险因素的患者每年行MRI。
- 1部指南对上述患者不提供MRI,其余指南结论不确定。
临床应用与阅片要点
- 作者结论认为,对无复发风险增加的患者,随访中不应提供MRI。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Present article will perform a review regarding the current recommendations of Magnetic resonance imaging (MRI) in routine follow-up after successfully treated breast cancer by surgery, radiation and/or systemic therapy.
METHODS: For this review, a literature review search was done with the MeSH-terms: Magnetic Resonance Imaging, breast neoplasm, post-operative period and follow-up, according to PRISMA. The literature published between 2006 and 2016 in MedBase, PubMed and Embase was consulted.
RESULTS: The 10 articles and 8 guidelines were analysed for their recommendations regarding MRI use in routine follow-up for breast cancer. One article concluded that MRI could influence further policy, all others did not find superiority of MRI over mammography or were inconclusive. One guideline recommended annual MRI for patients with a positive personal history (PPH) for breast cancer without further risk factors, one guideline offered no MRI to these patients and all other guidelines were inconclusive.
CONCLUSION: There is insufficient evidence regarding superiority of MRI versus mammography in routine follow-up for patients with a PPH of breast cancer. MRI does not improve survival in all patients and should therefore not be offered to patients in follow-up without increased risk for recurrences.
引用
- van Bodegraven EA, van Raaij JC, Van Goethem M, et al. Guidelines and recommendations for MRI in breast cancer follow-up: A review. Eur J Obstet Gynecol Reprod Biol. 2017. PMID: 28926729. doi:10.1016/j.ejogrb.2017.09.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。